Of the patient population, 85.7% (12 patients) with cervical cancer were HER3-high at initial diagnosis (Fig. 3a and Additional file 6: Table S6); 85.7% (12 patients) were also HER3-high at recurrence (Fig. 3a, b). Here, ERBB3 is linked to cervical carcinoma.